I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 1 dose-finding study of rebastinib (DCC-2036) in pati..:
Cortes, Jorge
;
Talpaz, Moshe
;
Smith, Hedy P
...
qt05j6n5zc. , 2017
Link:
https://escholarship.org/uc/item/05j6n5zc
RT Journal T1
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt05j6n5zc&Exemplar=1&LAN=DE A1 Cortes, Jorge A1 Talpaz, Moshe A1 Smith, Hedy P A1 Snyder, David S A1 Khoury, Jean A1 Bhalla, Kapil N A1 Pinilla-Ibarz, Javier A1 Larson, Richard A1 Mitchell, David A1 Wise, Scott C A1 Rutkoski, Thomas J A1 Smith, Bryan D A1 Flynn, Daniel L A1 Kantarjian, Hagop M A1 Rosen, Oliver A1 Van Etten, Richard A PB eScholarship, University of California YR 2017 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Pediatric K1 Rare Diseases K1 Patient Safety K1 Hematology K1 Cancer K1 Neurosciences K1 Pediatric Cancer K1 Childhood Leukemia K1 Clinical Research K1 6.2 Cellular and gene therapies K1 Evaluation of treatments and therapeutic interventions K1 6.1 Pharmaceuticals K1 Adult K1 Aged K1 80 and over K1 Drug Monitoring K1 Drug Resistance K1 Neoplasm K1 Female K1 Fusion Proteins K1 bcr-abl K1 Humans K1 Leukemia K1 Myelogenous K1 Chronic K1 BCR-ABL Positive K1 Myeloid K1 Acute K1 Male K1 Maximum Tolerated Dose K1 Middle Aged K1 Mutation K1 Protein Kinase Inhibitors K1 Quinolines K1 Treatment Outcome K1 Young Adult K1 Cardiorespiratory Medicine and Haematology K1 Immunology K1 Cardiovascular medicine and haematology JF qt05j6n5zc LK http://dx.doi.org/https://escholarship.org/uc/item/05j6n5zc DO https://escholarship.org/uc/item/05j6n5zc SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)